Among the highlights of WCLC are final overall survival (OS) data from AstraZeneca's FLAURA 2 study of EGFR inhibitor Tagrisso (osimertinib) given in combination with chemotherapy as a first-line ...
As of the end of June 2025, the most recent reporting period, 117.3 million people had been forced to flee their homes globally due to persecution, conflict, violence, human rights violations or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback